¼¼°èÀÇ ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Ä¡·á À¯Çüº°, ¾Ë·¹¸£±â À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº° ºÐ¼®(2023-2030³â)
Global Allergy Immunotherapy Market Size study & Forecast, by Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy ) by Allergy Type, by Distribution Channel and Regional Analysis, 2023-2030
»óǰÄÚµå : 1381655
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2023³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,814,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,604,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾Ë·¹¸£±â ¸é¿ª¿ä¹ý ¼¼°è ½ÃÀåÀº 2022³â ¾à 20¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â µ¿¾È 9.0% ÀÌ»óÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾Ë·¹¸£±â ¸é¿ª¿ä¹ýÀº ¾Ë·¹¸£±â¿¡ ´ëÇÑ ÀÇÇÐÀû Ä¡·á¹ýÀÔ´Ï´Ù. ²É°¡·ç, Áøµå±â, ¹Ý·Áµ¿¹°ÀÇ ºñµë, ƯÁ¤ °ïÃæ µ¶°ú °°Àº ƯÁ¤ ¾Ë·¹¸£°Õ¿¡ ´ëÇÑ ¸é¿ª ü°èÀÇ °¨ÀÛÀ» ¸ñÇ¥·Î ÇÏ´Â Àå±âÀûÀÎ Ä¡·á¹ýÀÔ´Ï´Ù. ¾Ë·¹¸£±â ¸é¿ª¿ä¹ýÀÇ ¸ñÀûÀº ¾Ë·¹¸£±â Ç׿ø¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀÀ» º¯È­½ÃÄÑ ¾Ë·¹¸£±â Áõ»óÀ» ¿ÏÈ­ÇÏ´Â °ÍÀÔ´Ï´Ù. ¾Ë·¹¸£±â¼º ºñ¿°(²É°¡·ç ¾Ë·¹¸£±â), ¾Ë·¹¸£±â¼º õ½Ä, °ïÃæµ¶ ¾Ë·¹¸£±â Ä¡·á¿¡ È¿°úÀûÀÔ´Ï´Ù. ¾Ë·¹¸£±â ¿¹¹æÁÖ»ç´Â Ä¡·á Á¾·á ÈÄ¿¡µµ Àå±â°£ Áõ»óÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý ½ÃÀåÀº ´Ù¾çÇÑ Á¾·ùÀÇ ¾Ë·¹¸£±â ºÎ´ã Áõ°¡, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù.

American College of Allergy, Asthma &ImmunologyÀÇ Á¤º¸¿¡ µû¸£¸é, ¸Å³â 5,000¸¸ ¸í ÀÌ»óÀÇ ¹Ì±¹ÀÎÀÌ ¾Ë·¹¸£±â¸¦ ¾Î°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ½Ì±ÛÄɾî(SingleCare)°¡ 2022³â 1¿ù¿¡ ¹ßÇ¥ÇÑ Çмú ³í¹®¿¡ µû¸£¸é, ¸Å³â 5õ¸¸ ¸í ÀÌ»óÀÇ ¹Ì±¹ÀÎÀÌ ¾î¶² Á¾·ùÀÇ ¾Ë·¹¸£±â¸¦ °æÇèÇϰí ÀÖ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¸¶Âù°¡Áö·Î 2050³â Àεµ Àü¿ªÀÇ ³ëÀΠõ½Ä ȯÀÚ ¼ö´Â ¾à 2,540¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¾Ë·¹¸£±â´Â ¹Ì±¹¿¡¼­ 6¹øÂ°·Î ÈçÇÑ ¸¸¼ºÁúȯÀ¸·Î ²ÅÈ÷°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Ì±ÛÄɾ 2021³â¿¡ ½Ç½ÃÇÑ ¼³¹®Á¶»ç¿¡ µû¸£¸é, ¾Ë·¹¸£±â°¡ ÀÖ´Â ÀÀ´äÀÚÀÇ 82.0%°¡ ¹Ì±¹¿¡¼­ ¾Ë·¹¸£±â°¡ »îÀÇ Áú¿¡ ¿µÇâÀ» ¹ÌÄ£´Ù°í »ý°¢ÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÀÌó·³ Àü ¼¼°èÀûÀ¸·Î ¾Ë·¹¸£±â À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼³ÇÏ Åõ¿© Á¦Á¦ÀÇ ±â¼ú ¹ßÀü°ú °­·ÂÇÑ Á¦Ç° ÆÄÀÌÇÁ¶óÀÎÀÇ Á¸Àç´Â ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾Ë·¹¸£±â ¸é¿ª¿ä¹ýÀÇ ³ôÀº ¿¬±¸ ºñ¿ë, ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý »ç¿ë¿¡ µû¸¥ ´ÜÁ¡, ´ëü Ä¡·á¹ýÀÇ °¡¿ë¼ºÀº 2023-2030³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¼¼°è ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« µîÀÔ´Ï´Ù. ºÏ¹Ì´Â ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷ÀÇ ¿ìÀ§, ¾Ë·¹¸£±â ÁúȯÀÇ Áõ°¡, ÀÌ Áö¿ª¿¡¼­ÀÇ Á¦Ç° Ãâ½Ã Ȱµ¿ Áõ°¡·Î ÀÎÇØ 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº Áúº´ ¹ßº´·ü Áõ°¡, ÁÖ¿ä ½ÃÀå Âü¿©ÀÚµéÀÇ »ç¾÷ È®Àå, Áö¿ª ³» ÀÎ½Ä Á¦°í ÇÁ·Î±×·¥ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ °¡Àå ºü¸¥ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

Á¦3Àå ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý ¼¼°è ½ÃÀå ¿ªÇÐ

Á¦4Àå ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý ¼¼°è ½ÃÀå »ê¾÷ ºÐ¼®

Á¦5Àå ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý ¼¼°è ½ÃÀå : Ä¡·á À¯Çüº°

Á¦6Àå ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý ¼¼°è ½ÃÀå : ¾Ë·¹¸£±â À¯Çüº°

Á¦7Àå ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý ¼¼°è ½ÃÀå : À¯Åë ä³Îº°

Á¦8Àå ¾Ë·¹¸£±â ¸é¿ª¿ä¹ý ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

Á¦9Àå °æÀï Á¤º¸

Á¦10Àå Á¶»ç °úÁ¤

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Allergy Immunotherapy Market is valued at approximately USD 2.07 billion in 2022 and is anticipated to grow with a growth rate of more than 9.0% over the forecast period 2023-2030. Allergy immunotherapy is a medical treatment for allergies. It is a long-term therapy that aims to desensitize a person's immune system to specific allergens, such as pollen, dust mites, pet dander, or certain insect venoms. The goal of allergy immunotherapy is to modify the immune response to allergens, leading to a reduction in allergy symptoms. It can be effective in treating allergic rhinitis (hay fever), allergic asthma, and insect venom allergies. Allergy shots can provide long-term relief, even after the treatment is completed. The Allergy Immunotherapy market is expanding because of factors such as the increasing burden of various types of allergies and rising demand for personalized medicine.

According to Information form the American College of Allergy, Asthma & Immunology, more than 50 million Americans suffer from allergies each year. In addition, for instance, a journal paper published by SingleCare in January 2022 estimates that more than 50.0 million Americans experience an allergy of some form each year. Similarly, The number of cases of asthma in Indian senior citizens across the India in 2050 was anticipated to be about 25.4 million cases. Furthermore, it noted that allergies rank as the sixth-most prevalent chronic illness in the US. In addition, a survey conducted by SingleCare in 2021 found that 82.0% of respondents who had allergies felt their allergies had an impact on their quality of life in the US. Thus, rising incidence of allergies across the regions is driving the market growth. In addition, technological advancements in sublingual dosage formulations and presence of strong product pipeline are creating a lucrative opportunity to the market growth. However, the high cost of allergy immunotherapy research and drawbacks associated with the use of allergy immunotherapy and availability of alternative treatments stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Allergy Immunotherapy Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the dominance of key market players, rising prevelance of allergy disorders, rising number of product launch activities in the region. Whereas, Asia Pacific region is projected to have fastest growth owing to factors such as rising disease prevelance, rising expansion by key market players in the region as well as rising number of awareness programs in the region.

Major market player included in this report are:

Recent Developments in the Market:

Global Allergy Immunotherapy Market Report Scope:

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

By Allergy Type:

By Distribution Channel:

By Region:

Table of Contents

Chapter 1. Executive Summary

Chapter 2. Global Allergy Immunotherapy Market Definition and Scope

Chapter 3. Global Allergy Immunotherapy Market Dynamics

Chapter 4. Global Allergy Immunotherapy Market: Industry Analysis

Chapter 5. Global Allergy Immunotherapy Market, by Treatment Type

Chapter 6. Global Allergy Immunotherapy Market, by Allergy Type

Chapter 7. Global Allergy Immunotherapy Market, by Distribution Channel

Chapter 8. Global Allergy Immunotherapy Market, Regional Analysis

Chapter 9. Competitive Intelligence

Chapter 10. Research Process

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â